Laura Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Laura Williams has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Richard B. Reilly
The University of Dublin
14 shared publications - John S. Butler
Centre for Eye Research Ireland (CERI), Sustainability and Health Research Hub (SHRH), Technological University Dublin, D07 H6K8 Dublin, Ireland
13 shared publications - Michael Hutchinson
St Vincent’s University Hospital
9 shared publications - Hugo Morales‐Briceño
Movement Disorders Unit, Neurology Department Westmead Hospital Westmead New South Wales Australia
8 shared publications Brendan Quinlivan
Trinity Centre for Bioengineering, Trinity College Dublin Dublin Ireland
7 shared publicationsInes Beiser
Department of Neurology, St Vincent's University Hospital Dublin, Dublin, Ireland
7 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
Parkinson's through a cultural lens: Diversity in disease expression and care
Living and care experiences with Parkinson's disease (PD) vary widely across cultures. Global heterogeneity in PD disease expression is increasingly recognized, shaped by differences in genetic backgrounds, environmental exposures, socioeconomic conditions, and access to healthcare resources. Cultural beliefs, levels of health literacy, and stigma play a critical role in shaping how individuals perceive their illness and influence when and how they seek medical care, their trust in healthcare providers, acceptance of diagnosis, and adherence to recommended treatments. Stigma—both internalized and externally imposed—can lead to social withdrawal, delayed help-seeking, and reduced quality of life. Caregiving experiences are likewise deeply influenced by sociocultural norms, including collectivist versus individualist value systems, gendered expectations, and familial structures, all of which affect the distribution of caregiving responsibilities and perceived caregiver burden. These cultural and structural dimensions contribute to marked disparities in diagnosis, treatment, and long-term support for PD across different populations. To address these inequities, clinical care models must be reoriented to incorporate cultural competence training for healthcare providers, locally tailored public education campaigns to combat stigma, and the development of culturally congruent support systems for patients and families. In parallel, future research must prioritize the inclusion of underrepresented populations and sociocultural contexts in epidemiological studies, clinical trials, and implementation science. Advancing culturally responsive, person-centered models of PD care is essential to dismantling structural barriers, reducing disparities, and promoting equitable outcomes for all people living with PD—regardless of geography, ethnicity, or cultural background.
- 12 May 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
Open AccessParkinson's through a cultural lens: Diversity in disease expression and care
Living and care experiences with Parkinson's disease (PD) vary widely across cultures. Global heterogeneity in PD disease expression is increasingly recognized, shaped by differences in genetic backgrounds, environmental exposures, socioeconomic conditions, and access to healthcare resources. Cultural beliefs, levels of health literacy, and stigma play a critical role in shaping how individuals perceive their illness and influence when and how they seek medical care, their trust in healthcare providers, acceptance of diagnosis, and adherence to recommended treatments. Stigma—both internalized and externally imposed—can lead to social withdrawal, delayed help-seeking, and reduced quality of life. Caregiving experiences are likewise deeply influenced by sociocultural norms, including collectivist versus individualist value systems, gendered expectations, and familial structures, all of which affect the distribution of caregiving responsibilities and perceived caregiver burden. These cultural and structural dimensions contribute to marked disparities in diagnosis, treatment, and long-term support for PD across different populations. To address these inequities, clinical care models must be reoriented to incorporate cultural competence training for healthcare providers, locally tailored public education campaigns to combat stigma, and the development of culturally congruent support systems for patients and families. In parallel, future research must prioritize the inclusion of underrepresented populations and sociocultural contexts in epidemiological studies, clinical trials, and implementation science. Advancing culturally responsive, person-centered models of PD care is essential to dismantling structural barriers, reducing disparities, and promoting equitable outcomes for all people living with PD—regardless of geography, ethnicity, or cultural background.
- 11 May 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (8) , 1993-2001
Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease
- 11 May 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (8) , 1993-2001
Addressing Care Partner Burden from the Underrecognition of Iatrogenic Sexual Behavior Changes in Parkinson's Disease
- 27 April 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (10) , 2453-2457
Age at Onset Predicts Motor and Non‐motor Severity in Cervical Dystonia
Background: Cervical dystonia (CD) is the most common focal dystonia and shows significant heterogeneity in both motor and non‐motor symptoms. Although motor symptoms typically prompt clinical presentation, non‐motor features are the principal determinants of quality of life. Previous efforts to classify CD have focused on selected motor and non‐motor clinical characteristics, suggesting distinct subtypes with potential prognostic implications. Objective: We employed cluster analysis to identify phenotypic subgroups within a large CD population with detailed motor and non‐motor assessments. Methods: Adult patients with idiopathic isolated CD were included. Data were collected across five domains using validated instruments: motor severity (TWSTRS2‐Severity), quality of life (CDIP‐58 total and EQ‐5D‐5L utility index), disability (TWSTRS2‐Disability), pain (TWSTRS2‐Pain), and psychiatric symptoms (HADS‐Total). Hierarchical cluster analysis using Ward's linkage method was performed to identify phenotypic subgroups. Results: 201 CD patients (67% female) were included for analysis. Median age was 62 years. Hierarchical cluster analysis identified two distinct phenotypic subgroups (Clusters A and B). Cluster A patients (n = 78) demonstrated significantly earlier disease onset (35 vs 48 years) and greater symptom burden across all variables ( p < 0.001) when compared with Cluster B (n = 123). The largest between‐cluster differences were observed for CDIP‐58, HADS‐Total, and TWSTRS2‐Pain. Motor severity showed a smaller effect size, suggesting non‐motor features more strongly distinguish these phenotypes. Conclusion: Hierarchical cluster analysis identified two distinct CD phenotypes: an earlier onset high‐burden subgroup and later onset low‐burden subgroup. These clusters were primarily distinguished by non‐motor features (quality of life, mood, pain, and disability). Our findings highlight age at onset as a key determinant of CD phenotype.
- 27 April 2026
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (10) , 2453-2457
Age at Onset Predicts Motor and Non‐motor Severity in Cervical Dystonia
Background: Cervical dystonia (CD) is the most common focal dystonia and shows significant heterogeneity in both motor and non‐motor symptoms. Although motor symptoms typically prompt clinical presentation, non‐motor features are the principal determinants of quality of life. Previous efforts to classify CD have focused on selected motor and non‐motor clinical characteristics, suggesting distinct subtypes with potential prognostic implications. Objective: We employed cluster analysis to identify phenotypic subgroups within a large CD population with detailed motor and non‐motor assessments. Methods: Adult patients with idiopathic isolated CD were included. Data were collected across five domains using validated instruments: motor severity (TWSTRS2‐Severity), quality of life (CDIP‐58 total and EQ‐5D‐5L utility index), disability (TWSTRS2‐Disability), pain (TWSTRS2‐Pain), and psychiatric symptoms (HADS‐Total). Hierarchical cluster analysis using Ward's linkage method was performed to identify phenotypic subgroups. Results: 201 CD patients (67% female) were included for analysis. Median age was 62 years. Hierarchical cluster analysis identified two distinct phenotypic subgroups (Clusters A and B). Cluster A patients (n = 78) demonstrated significantly earlier disease onset (35 vs 48 years) and greater symptom burden across all variables ( p < 0.001) when compared with Cluster B (n = 123). The largest between‐cluster differences were observed for CDIP‐58, HADS‐Total, and TWSTRS2‐Pain. Motor severity showed a smaller effect size, suggesting non‐motor features more strongly distinguish these phenotypes. Conclusion: Hierarchical cluster analysis identified two distinct CD phenotypes: an earlier onset high‐burden subgroup and later onset low‐burden subgroup. These clusters were primarily distinguished by non‐motor features (quality of life, mood, pain, and disability). Our findings highlight age at onset as a key determinant of CD phenotype.
- Open Access
- 14 May 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 124, 107010
Genome sequencing reanalysis increases the diagnostic yield in dystonia
- 14 May 2024
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 124, 107010
Open AccessGenome sequencing reanalysis increases the diagnostic yield in dystonia
- 28 November 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 11 (1) , 76-85
DHDDS and NUS1: A Converging Pathway and Common Phenotype
Background: Variants in dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate synthase 1 (NUS1) cause a neurodevelopmental disorder, classically with prominent epilepsy. Recent reports suggest a complex movement disorder and an overlapping phenotype has been postulated due to their combined role in dolichol synthesis.Cases: We describe three patients with heterozygous variants in DHDDS and five with variants affecting NUS1. They bear a remarkably similar phenotype of a movement disorder dominated by multifocal myoclonus. Diagnostic clues include myoclonus exacerbated by action and facial involvement, and slowly progressive or stable, gait ataxia with disproportionately impaired tandem gait. Myoclonus is confirmed with neurophysiology, including EMG of facial muscles.Literature Review: Ninety‐eight reports of heterozygous variants in DHDDS, NUS1 and chromosome 6q22.1 structural alterations spanning NUS1, confirm the convergent phenotype of hypotonia at birth, developmental delay, multifocal myoclonus, ataxia, dystonia and later parkinsonism with or without generalized epilepsy. Other features include periodic exacerbations, stereotypies, anxiety, and dysmorphisms. Although their gene products contribute to dolichol biosynthesis, a key step in N‐glycosylation, transferrin isoform profiles are typically normal. Imaging is normal or non‐specific.Conclusions: Recognition of their shared phenotype may expedite diagnosis through chromosomal microarray and by including DHDDS/NUS1 in movement disorder gene panels.
- 28 November 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 11 (1) , 76-85
DHDDS and NUS1: A Converging Pathway and Common Phenotype
Background: Variants in dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate synthase 1 (NUS1) cause a neurodevelopmental disorder, classically with prominent epilepsy. Recent reports suggest a complex movement disorder and an overlapping phenotype has been postulated due to their combined role in dolichol synthesis.Cases: We describe three patients with heterozygous variants in DHDDS and five with variants affecting NUS1. They bear a remarkably similar phenotype of a movement disorder dominated by multifocal myoclonus. Diagnostic clues include myoclonus exacerbated by action and facial involvement, and slowly progressive or stable, gait ataxia with disproportionately impaired tandem gait. Myoclonus is confirmed with neurophysiology, including EMG of facial muscles.Literature Review: Ninety‐eight reports of heterozygous variants in DHDDS, NUS1 and chromosome 6q22.1 structural alterations spanning NUS1, confirm the convergent phenotype of hypotonia at birth, developmental delay, multifocal myoclonus, ataxia, dystonia and later parkinsonism with or without generalized epilepsy. Other features include periodic exacerbations, stereotypies, anxiety, and dysmorphisms. Although their gene products contribute to dolichol biosynthesis, a key step in N‐glycosylation, transferrin isoform profiles are typically normal. Imaging is normal or non‐specific.Conclusions: Recognition of their shared phenotype may expedite diagnosis through chromosomal microarray and by including DHDDS/NUS1 in movement disorder gene panels.
- 5 October 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 117, 105864
ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle
- 5 October 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 117, 105864
ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle
- 24 August 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (S3) , S54-S57
Seeing What Is Not There: Revisiting a Diagnostic Conundrum in the Clinic
- 24 August 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (S3) , S54-S57
Seeing What Is Not There: Revisiting a Diagnostic Conundrum in the Clinic
- 15 February 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (4) , 704-706
NOTCH2NLC GGC Repeat Expansion Presenting as Adult‐Onset Cervical Dystonia
- 15 February 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (4) , 704-706
NOTCH2NLC GGC Repeat Expansion Presenting as Adult‐Onset Cervical Dystonia
- 1 October 2022
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 51 (10) , 778-785
Challenges in managing late-stage Parkinson’s disease: Practical approaches and pitfalls
In late-stage Parkinson’s disease there is a shift to increasing disability from non-motor symptoms unresponsive to levodopa.
- 1 October 2022
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 51 (10) , 778-785
Challenges in managing late-stage Parkinson’s disease: Practical approaches and pitfalls
In late-stage Parkinson’s disease there is a shift to increasing disability from non-motor symptoms unresponsive to levodopa.
- 1 August 2022
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 51 (8) , 577-583
An approach to acute clinical deterioration in patients with late-stage Parkinson’s disease
Late-stage Parkinson’s disease is a syndrome of frequent falls, cognitive impairment, visual hallucinations and need for residential care.
- 1 August 2022
- Published by The Royal Australian College of General Practitioners in Australian Journal of General Practice
- Vol. 51 (8) , 577-583
An approach to acute clinical deterioration in patients with late-stage Parkinson’s disease
Late-stage Parkinson’s disease is a syndrome of frequent falls, cognitive impairment, visual hallucinations and need for residential care.